Healthgen Biotechnology

Company Deals

Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares

Fineline Cube Oct 20, 2025

Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved...

Company Drug

Healthgen Biotechnology’s Plant-Made Albumin Breakthrough: A Milestone in Serum Therapy

Fineline Cube Dec 1, 2024

On November 30th, Healthgen Biotechnology Corp. announced a significant research outcome at the 9th Pharmaceutical...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod